Sanofi-aventis
São Paulo, Brazil
NCT Number: NCT00664391
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Breeze.
Looking for future studies?
Notify Me18 year–60 year
Female
Interventional
Phase 3
São Paulo, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Liquid soup to be applied in the external genital area, in small quantity, with abundantly rinse after use, during 21 days
Time frame: 21 days
Sanofi
Industry
Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07464405
Health Behaviour, Hygiene
Kırklareli, Turkey (Türkiye)
View Trial DetailsNCT07341035
Genital Hygiene, Hygiene
Çankırı, Turkey (Türkiye)
View Trial DetailsNCT06697210
Biofilm Removal, Healthy
Sant Cugat del Vallès, Barcelona, Spain
View Trial DetailsNCT06316505
Hygiene, Motivation
Erzurum, Turkey (Türkiye)
View Trial Details